TBWA
IMNM icon

Three Bridge Wealth Advisors’s Immunome IMNM Stock Holding History

Three Bridge Wealth Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,615
Closed -$823K – 92
2026
Q1 		$823K Hold
37,615
– – 0.23% 45
2025
Q4 		$808K Hold
37,615
– – 0.21% 44
2025
Q3 		$440K Hold
37,615
– – 0.11% 64
2025
Q2 		$350K Hold
37,615
– – 0.09% 80
2025
Q1 		$253K Buy
37,615
+10,000
+36% +$95.9K 0.09% 76
2024
Q4 		$293K Buy
+27,615
New +$334K 0.1% 75

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Three Bridge Wealth Advisors's IMNM Position: Q2 2026 in Review

Three Bridge Wealth Advisors sold out of Immunome (IMNM) in Q2 2026, closing a stake of 37,615 shares — an estimated $823K sold.

Three Bridge Wealth Advisors first reported a position in IMNM in Q4 2024 and held it in 6 quarters. The position peaked at $823K in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Three Bridge Wealth Advisors reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
  • Three Bridge Wealth Advisors sold 37,615 Immunome shares in Q2 2026, an estimated $823K.
  • Three Bridge Wealth Advisors first reported a position in Immunome in Q4 2024 and held it in 6 quarters.
  • Three Bridge Wealth Advisors's Immunome position peaked at $823K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Three Bridge Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.